Synta Pharma (SNTA) Enters 1.25M Common Sales Agreement at $4.01/Share
Tweet Send to a Friend
Synta Pharmaceuticals Corp. (Nasdaq: SNTA) announced the entry into a Subscription Agreement with an entity affiliated with Bruce Kovner, one ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE